CERo Therapeutics Holdings, Inc. - Common Stock (NQ:CERO)

0.0951 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CERo Therapeutics Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 05, 2025

Via Benzinga

CERo Therapeutics Receives FDA Fast Track Designation for CER-1236 in Acute Myeloid Leukemia (AML)

September 05, 2025

From CERo Therapeutics Holdings, Inc.

Via GlobeNewswire

Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket ↗

September 05, 2025

Via Benzinga

CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236

July 31, 2025

From CERo Therapeutics Holdings, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 23, 2025

Via Benzinga

Top movers in Monday's after hours session ↗

June 23, 2025

After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

CERo Therapeutics Holdings, Inc. Announces First Patient Completes Dose-Limiting Toxicity Observation Period with No Reported DLTs in Phase 1 Trial of CER-1236

June 23, 2025

From CERo Therapeutics Holdings, Inc.

Via GlobeNewswire

Which stocks are experiencing notable movement on Wednesday? ↗

June 18, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 18, 2025

Via Benzinga

Dow Surges 150 Points; Korn Ferry Earnings Top Views ↗

June 18, 2025

Via Benzinga

Topics Stocks

Here are the top movers in Wednesday's session. ↗

June 18, 2025

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Which stocks are gapping on Wednesday? ↗

June 18, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 18, 2025

Via Benzinga

Topics Cannabis

Wondering what's happening in today's pre-market session? ↗

June 18, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 18, 2025

Via Benzinga

US Stocks Likely To Open Higher Despite Trump's 'Unconditional Surrender' Call: All Eyes On Powell As Experts Predict Inflation Will Limit Fed's Rate Cut Capacity ↗

June 18, 2025

U.S. futures were higher on Wednesday as oil futures tumbled after Donald Trump called for an "Unconditional Surrender" by Iran late Tuesday.

Via Benzinga

Topics Economy Government

Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket ↗

June 18, 2025

Via Benzinga

Dow Dips Around 300 Points As Israel-Iran Conflict Escalates: Investor Sentiment Declines, Fear & Greed Index Moves To 'Neutral' Zone ↗

June 18, 2025

Via Benzinga

Topics Stocks

Cero Therapeutics Rockets On FDA Orphan Drug Status For Blood Cancer Drug; Retail Bulls Feel Stock 'Still Has A Few Pumps Left' ↗

June 17, 2025

CER-1236 is designed to engineer T cells with phagocytic, or target-cell "eating," functions alongside traditional cancer-killing mechanisms.

Via Stocktwits

Top movers in Tuesday's after hours session ↗

June 17, 2025

Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Crude Oil Rises Sharply; Jabil Earnings Top Views ↗

June 17, 2025

Via Benzinga

US Stocks Lower; Retail Sales Decline In May ↗

June 17, 2025

Via Benzinga

Peraso Inc (NASDAQ: PRSO) Deploys Stealth Tech Shipment for Military Use – Tapping $500M NATO Market – More Stocks Inside

June 17, 2025

Via AB Newswire

Which stocks are gapping on Tuesday? ↗

June 17, 2025

The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

What's Going On With Cero Therapeutics Stock Tuesday? ↗

June 17, 2025

CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares are trading higher Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236.

Via Benzinga

Get insights into the top gainers and losers of Tuesday's pre-market session. ↗

June 17, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

CERo Therapeutics Holdings, Inc. Announces FDA Orphan Drug Designation Granted to CER-1236 for the Treatment of Acute Myeloid Leukemia (AML)

June 17, 2025

From CERo Therapeutics Holdings, Inc.

Via GlobeNewswire

CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split

June 11, 2025

From CERo Therapeutics Holdings, Inc.

Via GlobeNewswire

Get insights into the top gainers and losers of Monday's pre-market session. ↗

June 09, 2025

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

US Stocks Likely To Open On A Mixed Note After S&P 500 Scales 6,000-Mark: 'Whole Globe Is In A Bull Market' ↗

June 09, 2025

U.S. stock futures were flat on Monday after closing higher on Friday. Futures of major benchmark indices were mixed in premarket.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.